Child Delivery Using an Elective C- Section
Conditions
Keywords
Chitosan, Plasma, Incision Closure
Brief summary
The purpose of this study is to assess the safety and performance of the BioWeld1 System procedure for surgical incision closure of the skin in women scheduled for elective C-section procedure.
Detailed description
In every surgical procedure, there is a need to close the incision that was made. Current methods for incision closure include stitching, gluing and stapling. Some of these methods are time consuming, have potential for infection and may leave a significant scar. The bioWeld1 technology suggests a new approach for incision closure. It is a novel medical device that consists of a Chitosan film and the BioWeld1 plasma ejecting device. The Chitosan film is intended to be applied to the skin incision, while the BioWeld1device is used for welding the Chitosan to the skin by means of cold plasma technology.
Interventions
DEVICEBioWeld1 System
External skin layer closure of C-section incision by the BioWeld1 system. Removal of Chitoplast on day 4-7 post procedure.
Sponsors
IonMed Ltd
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
1. Age between 20 to 40 years old. 2. Women scheduled for child delivery using an elective C- section. 3. Women in their first or second pregnancy having a C-section for the first time 4. Healthy women with no systemic diseases such as diabetes, heart disease etc. 5. Women with average weight, BMI prior pregnancy of 18.5-25. 6. Women with no skin diseases 7. Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study-specific tests or procedures are performed. 8. The subject commits to return for the scheduled post-operative follow-up visits at the clinic General
Exclusion criteria
1. Women intended for any abdominal surgery other than C-section procedure 2. Women intended for C-section procedure for other purpose than child delivery 3. Any prior C-section procedure for any purpose 4. Women Received/Receiving radiotherapy or chemotherapy of any kind. 5. Women receiving steroids or any other medication that interferes with wound healing. 6. Women receiving Acutan in the last half year. 7. Women with bleeding diathesis or hypercoagulable state. 8. Women with prior cosmetic or medical treatment in the target area (e.g. phosphatydilcholine injections). 9. Women suffering from Thrombocytopenia (platelets count\<100,000/mm3) pre-procedure. 10. Women who is currently participating or have participated in an investigational study, other than this study, within the past 60 days. 11. Psychiatric background. Intra operative
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety | Within 21 days post procedure | Frequency and severity of incision closure procedure-related adverse events (burns, wound dehiscence or need for additional surgical procedure of the skin wound). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Performance | At 21 days post procedure | The following secondary variables will be examined: 1. Complete epidermal closure. 2. Redness and edemas grade \<1 in at least 87% of the subjects. 3. Encrustation grade \<1 in at least 87% of the subjects. 4. Discharge from wound is negative in at least 87% of the subjects. 5. Photographic evidence of clean healing in at least 30% of the cases. |
Countries
Israel
Outcome results
None listed